Linyi and TaizhouJune 18, 2026 /PRNewswire/ — On June 15, 2026, Xinweijie Medical successfully held a brand renewal and new product launch event under the theme “Gathering Core Strength, Opening a New Chapter.” This launch marks a comprehensive upgrade of Xinweijie Medical’s visual identity, brand connotation, and business strategy. The rebranded Xinweijie will focus on the high-end drug delivery device track, leveraging rapid product development and efficient manufacturing capabilities to bridge the entire chain from concept to commercialization, embarking on a new journey.
Brand Renewal: A Strategic Leap from “Gangan” to “Xinweijie”
At the launch event, Mr. Zhang Hongdao, CEO of Xinweijie Medical, delivered a speech, providing an in-depth interpretation of the brand renewal strategy and the company’s future development layout. He stated that the global precision drug delivery technology is rapidly evolving, the biologics market continues to expand, and clinical medical scenarios demand higher safety, user compliance, and intelligence levels from drug delivery devices. Traditional delivery equipment can no longer adapt to the current trends and clinical needs of the healthcare industry.
Facing this challenge, Xinweijie Medical has defined its brand mission and future direction. Mr. Zhang Hongdao emphasized: “The company’s mission is to improve patients’ quality of life with safe, simple, and humanized precision drug delivery devices.” This is not only the starting point of our product design but also Xinweijie’s commitment to every patient.
Driven by this mission, the company has established a clear development vision: to provide full-process support and services from concept to commercialization through rapid and effective product development and efficient, leading manufacturing capabilities; to become an innovation leader in drug delivery device solutions and a trusted preferred partner for global pharmaceutical companies.
Speech by Mr. Zhang Hongdao, CEO of Xinweijie Medical
This brand renewal is not merely a visual upgrade but a strategic advancement for Xinweijie, building on its past and looking toward the long term. In the future, Xinweijie will concentrate its core resources on deepening the entire business of R&D, production, and market sales of high-end drug delivery devices, focusing on tackling technical challenges in niche areas, and striving to become a leading enterprise in the high-end drug delivery device track.
At the launch event, Mr. Zhang Hongdao, CEO of Xinweijie Medical; Mr. Zhang Hao, Executive Director of Hillhouse Investment; Ms. Li Jing, Deputy Director of Huiyu Pharmaceutical Packaging Technology Research Institute; Mr. Chen Quanmin, Vice President of Global Formulation Products Business at Shanghai WuXi Biologics Technology Co., Ltd.; Mr. Yang Bin, Certification Officer at TÜV Rheinland; and Mr. Tian Shuo, Human Factors Engineer at Ganlee Pharmaceutical Co., Ltd., jointly took the stage to launch the Xinweijie Medical brand, marking the official start of a new growth cycle driven by the brand as a core force.
Xinweijie Medical Brand Upgrade Launch Ceremony
Major New Product Launch: Pen Injector Assembly (Spring-Driven)
The most anticipated segment of this launch event was the debut of Xinweijie’s new independently developed core product—the Pen Injector Assembly (Spring-Driven)—which fills market gaps with breakthrough technological innovation, injecting new momentum into industry channel development. This is a disposable, adjustable-dose, accurate and stable injection smart drug delivery system. Building on the safety advantages of traditional pre-filled products, the product achieves a comprehensive innovation in the injection mechanism:
Dose Accuracy—A stable and controllable spring-driven mechanism ensures precise and consistent dosing with each injection.
Simplified Operation—Innovatively eliminates the external structure of the rotary barrel and adds an automatic injection function after activation, streamlining the operation process and lowering the usage threshold.
Safety and Reliability—Effectively avoids operational errors, providing healthcare professionals and patients with a more convenient and safer precision dosing experience.
Launch of the Pen Injector Assembly (Spring-Driven) New Product
As a full-chain solution provider focused on high-end drug delivery devices, Xinweijie’s product portfolio extends far beyond this. Leveraging years of technical expertise and manufacturing advantages, the company has built a comprehensive product matrix covering diverse drug delivery scenarios, including pen injectors (reusable), pen injector assemblies (pre-filled), auto-injector assemblies, disposable pen needles, and other high-end delivery products, fully meeting diverse clinical needs from chronic disease long-term management to acute self-treatment.
The successful conclusion of this event is not only a concentrated showcase for Xinweijie Medical but also an important milestone in the synergistic development of the brand and channel ecosystem. In the future, Xinweijie Medical will continue to use technological innovation as its core engine, offering more competitive products, better service support, and richer market returns. It will deeply bind with all partners, work together to cultivate the blue ocean market of high-end drug delivery devices, and improve patients’ quality of life with safe, simple, and humanized precision drug delivery devices.